In recognition of Colon Cancer Awareness month, Cancer Connect hosted a webinar on March 16th. Join us as we take a closer look at how advancements in diagnostic testing are making it possible to detect recurrence earlier and assess treatment response better.
Using ctDNA to Optimize Colorectal Cancer Management
- What is a circulating tumor DNA test and how is it used to manage colorectal cancer?
- How a tumor informed approach may provide additional insight to inform treatment decisions
- Predicting relapse and identifying patients who may benefit from chemotherapy
The program was moderated by: John Strickler, M.D.
Associate Professor of Medicine, Associate Director Clinical Research – GI Oncology, Co-Leader, Duke Cancer Institute Molecular Tumor Board, Duke University